GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines
GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the…
Read More...
Read More...
